- Revising Breast Screening Guidelines for Atypical Lesions
- Study Identifies Factors Predicting Long-Term Survival Benefits with Immunotherapy
- Staying Away from Females Leads to Longer Lifespan?
- The first group of people who used the “magic weight-loss drug” are now doing?
- Prolonged Use of Earphones Linked to Irreversible Hearing Loss
- New research challenges traditional understanding of Parkinson’s disease
Pfizer recalls some batches of blood pressure drugs over a carcinogen
- Japan: Over 10,000 Applications for Health Damage from COVID-19 Vaccines
- Antioxidant Supplementation May Accelerate Tumor Growth and Spread
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- ‘Elixir of Immortality’ Nicotinamide Riboside (NR) Virtually No Effect
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Pfizer recalls some batches of blood pressure drugs over a carcinogen.
U.S. pharmaceutical giant Pfizer said on April 22 that it was recalling five batches of its blood pressure drug Accupril after it found elevated levels of a potential carcinogen in its blood pressure drug, Reuters just reported.
Pfizer said it has not identified any reports of adverse events related to the recalled batches. The drugs were sold in the U.S. and Puerto Rico from December 2019 to April 2022.
Pfizer Canada also recalled all batches of three doses of Accupril on Thursday after finding the same impurity above acceptable levels.
Pfizer said nitrosamines have been found in the drug, but there is no immediate risk to patients taking the drug.
Nitrosamines are common in water and food, but chronic intake of nitrosamines above acceptable levels increases the risk of cancer.
Pfizer last month also recalled some batches and two authorized cheaper versions of another blood pressure drug, Accuretic, because of a possible carcinogen in it.
News on March 27
On March 21, Pfizer voluntarily recalled 3 commonly used antihypertensive drugs because of a notice of voluntary recall of drugs.
Half a month ago, on March 4, Pfizer Canada recalled the same blood pressure lowering drug in the Canadian market. The reasons for the two recalls are also the same.
In the past five years, Pfizer has recalled a total of 14 times across the United States, involving 16 drugs, and has repeatedly been caught in the “recall door”. of global pharmaceutical companies continue to face doubts about the quality and safety of medicines.
(source:internet, reference only)
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.